Lindbrook Capital’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
Lindbrook Capital's CLB Position: Q1 2025 in Review
Lindbrook Capital reduced its Core Laboratories (CLB) stake by 70% in Q1 2025, selling an estimated $12.5K and leaving 326 shares worth $4.89K. The position accounts for ﹤0.01% of the portfolio, ranked #1962.
Lindbrook Capital first reported a position in CLB in Q4 2019 and has held it in 22 quarters since. The position peaked at $107K in Q2 2021. 195 funds tracked by Wall St. Rank hold CLB as of Q1 2025.
- Lindbrook Capital held 326 shares of Core Laboratories worth $4.89K as of Q1 2025.
- Lindbrook Capital sold 747 Core Laboratories shares in Q1 2025, an estimated $12.5K.
- Core Laboratories made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1962 holding.
- Lindbrook Capital first reported a position in Core Laboratories in Q4 2019 and has held it in 22 quarters since.
- Lindbrook Capital's Core Laboratories position peaked at $107K in Q2 2021.
- 195 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2025.
Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.